By Cory Lewis, Chief Executive Officer and President, INCOG BioPharma Services
Meeting delivery timelines is a critical requirement for biopharma companies bringing a product to market. Receiving the drug “on time, every time” from an outsourcing partner is a challenging factor, according to customer surveys published in the “CDMO Outsourcing Models Edition” by ISR Reports.
Dealing with the inevitable challenges that arise from complex sterile injectable manufacturing operations is crucial for biopharma companies to meet their expectations of delivery timelines. Sponsors must evaluate a CDMO to ensure that an experienced, knowledgeable team is in place and their facility is equipped with flexible manufacturing systems. Review four key factors for improving on-time delivery when outsourcing drug product manufacturing and discover how investing in building a solid relationship with your CDMO will help improve timelines.